title: Experience with neoral cyclosporine through the oral route in liver transplantation.
authors.affiliation: General Surgery Department, Hospital Vall d'Hebron, Barcelona, Spain.
authors.forename: I
authors.initials: I
authors.lastname: Bilbao
authors.forename: J L
authors.initials: JL
authors.lastname: Lazaro
authors.forename: L
authors.initials: L
authors.lastname: Pou
authors.forename: R
authors.initials: R
authors.lastname: Charco
authors.forename: E
authors.initials: E
authors.lastname: Hildalgo
authors.forename: E
authors.initials: E
authors.lastname: Murio
authors.forename: C
authors.initials: C
authors.lastname: Margarit
mesh_terms: D000284:Administration, Oral; D016572:Cyclosporine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000188:drug therapy / Q000453:epidemiology* / Q000473:pathology; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D016031:Liver Transplantation / Q000276:immunology* / Q000401:mortality / Q000502:physiology; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D011446:Prospective Studies; D012086:Reoperation; D015996:Survival Rate; D016559:Tacrolimus / Q000627:therapeutic use; D013997:Time Factors
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine; D016559:Tacrolimus; D008775:Methylprednisolone